A Study of LY8888AX in Participants Using a Connected Insulin Management Platform

Clinical trial NCT05893797 · COMPLETED

Trial details

NCT number: NCT05893797
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Type 1 Diabetes Type 2 Diabetes Type 2 Diabetes Treated With Insulin

Start date: 2023-10-05
Primary completion: 2024-09-16
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.